Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agent.

Orciuolo, Enrico; Cecconi, Nadia; Galimberti, Sara; Papineschi, Federico; Petrini, Mario

Orciuolo, Enrico; Cecconi, Nadia; Galimberti, Sara; Papineschi, Federico; Petrini, Mario.

Leuk Res ; 31(9): 1321-3, 2007 Sep.

Article in En | MEDLINE | ID: mdl-17113639

Subject(s)

Antimetabolites, Antineoplastic/therapeutic use; Azacitidine/therapeutic use; Bone Marrow Transplantation; Cell Differentiation/drug effects; Myelodysplastic Syndromes/therapy; Vitamin D/analogs & derivatives; Adult; Female; Humans; Vitamin D/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Vitamin D / Myelodysplastic Syndromes / Cell Differentiation / Bone Marrow Transplantation / Antimetabolites, Antineoplastic Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Leuk Res Year: 2007 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links